Clinical Trials Logo

Asthma in Children clinical trials

View clinical trials related to Asthma in Children.

Filter by:

NCT ID: NCT05800379 Recruiting - Asthma in Children Clinical Trials

Study on Hospitalization of Children With Bronchial Asthma

Start date: July 1, 2023
Phase:
Study type: Observational

Bronchial asthma is the most common chronic respiratory disease in children. At present, more attention has been paid to the treatment of airway inflammation and smooth muscle spasm, while the related research on the risk factors of asthma attack, mucus plug formation and its effect on asthma has been ignored. This study was a retrospective study. Children hospitalized for acute exacerbation of asthma from 2016 to 2021 were selected as the research objects. The clinical manifestations, bronchoscopy results and lung CT results of children hospitalized for acute exacerbation of asthma were summarized. To analyze the risk factors of acute exacerbation, clinical characteristics, risk factors of mucus plug formation in hospitalized children with asthma, and the safety and efficacy of flexible bronchoscopy in the diagnosis and treatment of hospitalized children with asthma. The discharged children were investigated by written or online questionnaires to understand the acute attack of asthma, control level, compliance, appliability of the China Children's Asthma Action Plan, family management and medical utilization of children with asthma after discharge.

NCT ID: NCT05793866 Recruiting - Asthma in Children Clinical Trials

The Effect of Buteyko Breathing Technique on Asthma Control and Quality of Life in Children With Asthma

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

In this study, the effect of buteyko breathing technique applied in children aged 7-12 years with asthma disease on asthma control and quality of life is examined. Asthma is a serious global health problem affecting all age groups. In studies conducted with the ISSAC (International study of asthma and allergies in childhood) method, the prevalence of asthma varies between 4-23% in developed populations. In childhood prevalence studies in our country, the cumulative asthma prevalence was found to be between 13.7% and 15.3%. There are personal and environmental factors of genetic origin that cause asthma. Its prevalence is increasing in many countries, particularly among children. Asthma is a chronic inflammatory disease of the airways in which many cells and cellular elements play a role. It is seen with recurrent episodes of wheezing, coughing and shortness of breath due to lower airway obstruction and chronic inflammation. Nurses will contribute to the protection and improvement of patients' health and well-being, to control asthma, to increase the quality of life, and to reduce health care expenditures, thanks to the hands-on training they will give to patients with asthma. Keyword: Asthma, Quality of Life, Asthma Control

NCT ID: NCT05768399 Recruiting - Asthma in Children Clinical Trials

The Role of Biomarkers in the Occurrence and Development of Asthma

Start date: July 4, 2023
Phase:
Study type: Observational

To study the expression level of biomarkers such as GITRL in peripheral blood of children with asthma and analyze their correlation with the severity of asthma. To study the predictive value of biomarkers level for the occurrence and development of asthma. And to provide supplementary detection means and predictive indicators for the diagnosis of asthma and the severity of asthma.

NCT ID: NCT05765383 Enrolling by invitation - Asthma in Children Clinical Trials

Prognosis and Influencing Factors of Asthma in Children Aged 5-12 Years

Start date: August 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to 1)analyze the basic information of confirmed cases of asthma in children aged 5-12 years old hospitalized in the First Affiliated Hospital of Guangzhou Medical University from 2009 to 2020, 2)investigate the onset of asthma after 13 years old, 3)conducte lung function, blood and airway inflammation indicators, blood IL13 and IL1RL1 levels, 4)analyze the prognosis and influencing factors of children with asthma in this age group.Participants will be asked to fill a case report form and questionnaires. Besides, they should provide examination results like lung function, total IgE, expired nitric oxide, blood and sputum granulocyte counts, and determination of blood IL13 and IL1RL1 levels over the past 6 months.

NCT ID: NCT05762627 Not yet recruiting - Asthma in Children Clinical Trials

Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins

SAMP 2
Start date: March 2023
Phase:
Study type: Observational

Study of the clinical evolution at 10 years of children from the SAMP cohort (severe asthma, eosinophilic or not, allergic or not) in order to understand the different possible evolutions of these phenotypes at different ages.

NCT ID: NCT05744869 Not yet recruiting - Asthma in Children Clinical Trials

SBAT for Health Equity

Start date: August 1, 2025
Phase: N/A
Study type: Interventional

The goal of this research trial is to: 1) Solidify a population health SBAT implementation strategy with our longstanding community collaborators, 2) Perform a district-wide hybrid type 3, stepped-wedge, cluster randomized trial, and 3) Assess the supportive resource utilization and essential features of SBAT to extend sustainability and fidelity in a cost-effective manner.

NCT ID: NCT05742646 Completed - Obesity Clinical Trials

Managing AsThma AnD Obesity Related Symptoms (MATADORS) Feasibility Study

MATADORS
Start date: January 12, 2022
Phase: N/A
Study type: Interventional

The purpose of this 4 week pilot study is to test the use of a mobile application (also commonly referred to as an app) designed to help increase self-management strategies among youth that have asthma and obesity. The data obtained from this study will facilitate refinement of the app and interventional approaches for a future larger scale study to increase youth self-management of their clinical conditions, symptom management, and health maintenance as they transition to adulthood.

NCT ID: NCT05734261 Recruiting - Asthma in Children Clinical Trials

Forced Oscillations Technique During a Metacholine Test in Children

TPM AOS
Start date: September 7, 2023
Phase: N/A
Study type: Interventional

Asthma is the most common chronic lung disease in children. It affects more than 1 in 10 children in France. The methacholine bronchial challenge test (MBT) is indicated to assess the probability of asthma suggested by clinical symptoms by measuring the forced expiratory volume in one second (FEV1), after inhalation of a cumulative dose of methacholine. In children, the measurement of FEV1 requires a high level of cooperation from the child, which can be the source of false negatives or no result if this is not obtained. The objective of this study is to evaluate if the measurement of the respiratory function by the forced oscillations technique, allows to predict the variation of the FEV1 obtained

NCT ID: NCT05733299 Recruiting - Asthma Clinical Trials

Aflo™ Device Trial

AFLO
Start date: February 6, 2023
Phase: N/A
Study type: Interventional

This randomised, prospective, controlled parallel study aims to evaluate the role and potential of the aflo™ digital platform for improving asthma control, inhalation technique and adherence in patients who use metred dose inhalers (MDI). The study will recruit 104 patients with uncontrolled asthma in the North-West of Northern Ireland. Fifty two patients will remain on standard care over 24-weeks and 52 will combine standard care with the aflo™ platform. The data collected over a 24-week period will be used to determine 1. whether the aflo™platform improves inhalation technique and user adherence to prescribed medication and 2. Lead to better asthma control and reduced symptoms as measured by the Asthma Control Test (ACT). During the study clinicians will be able to remotely monitor and review user analytics via a clinical dashboard. ACT measurements will be recorded at start and end of study. The study aims to test the functionality and impact of automated inhaler technique with real-time feedback, adherence prompts and air quality data sharing for patients who use metered dose inhalers (MDI) using the newly developed aflo™ digital respiratory management platform.

NCT ID: NCT05728385 Not yet recruiting - Asthma in Children Clinical Trials

Impact of Modified Specific Carbohydrate Diet on Bronchial Asthma Control in Children

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study will explore if the specific carbohydrate diet has an effect on asthma control in children and if it will affect the frequency, severity, and duration of asthma and thus provide it as a potential complementary treatment option for them.